MedTrace Logo

Evaluating the Efficacy of SyMRI in Clinical Pediatric Populations

NCT03494855 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2019-07-16

No results posted yet for this study

Summary

Synthetic MR Technologies has created a quantified imaging solution - SyMRI - to enable radiologists to acquire quantified images and always obtain the best contrast images. This study represents an attempt to assess the clinical utility of this software.

Conditions

  • Brain Injuries
  • Brain Development Abnormality
  • Brain Pathology

Interventions

DEVICE

SyMRI Software

The MDME sequence aims to provide whole absolute quantification of T1, T2, PD and B1 inhomogeneity in 5 minutes at typical clinical resolution (0.8 x 0.8 x 5mm). SyMRI software then allows a user to synthesize any almost image contrast (T1, T2, PD, FLAIR, IR, DIR, etc) by adjusting imaging parameters after the fact.

Sponsors & Collaborators

  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Manohar Shroff, MD · The Hospital for Sick Children

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-01
Primary Completion
2018-08-22
Completion
2019-01-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03494855 on ClinicalTrials.gov